The presence of this BRAF mutation was associated with a significantly higher risk of dying from cancer-related causes, independently of other factors such as age, gender, PS, KRAS status, pathological finding, number of metastases, and metastatic sites [61]. The gene discussed is KRAS; the disease is cancer.